89 related articles for article (PubMed ID: 1720100)
1. Oral N-acetylcysteine reduces bleomycin-induced collagen deposition in the lungs of mice.
Shahzeidi S; Sarnstrand B; Jeffery PK; McAnulty RJ; Laurent GJ
Eur Respir J; 1991 Jul; 4(7):845-52. PubMed ID: 1720100
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters.
Giri SN; Hyde DM; Schiedt MJ
J Lab Clin Med; 1988 Jun; 111(6):715-24. PubMed ID: 2453601
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Pardo A; Ruiz V; Arreola JL; Ramírez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
[TBL] [Abstract][Full Text] [Related]
4. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats.
Cortijo J; Cerdá-Nicolás M; Serrano A; Bioque G; Estrela JM; Santangelo F; Esteras A; Llombart-Bosch A; Morcillo EJ
Eur Respir J; 2001 Jun; 17(6):1228-35. PubMed ID: 11491169
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
6. Partial reversal of established bleomycin-induced pulmonary fibrosis by rh-urokinase in a rat model.
Hart DA; Whidden P; Green F; Henkin J; Woods DE
Clin Invest Med; 1994 Apr; 17(2):69-76. PubMed ID: 7516275
[TBL] [Abstract][Full Text] [Related]
7. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
9. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
[TBL] [Abstract][Full Text] [Related]
10. Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis.
Gao J; Huang Y; Li P; Xu D; Li J; Liu Y; Huang Z; Wu Q; Shao X
J Ethnopharmacol; 2011 Jun; 136(1):21-6. PubMed ID: 21421041
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
[TBL] [Abstract][Full Text] [Related]
13. Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats.
Mata M; Ruíz A; Cerdá M; Martinez-Losa M; Cortijo J; Santangelo F; Serrano-Mollar A; Llombart-Bosch A; Morcillo EJ
Eur Respir J; 2003 Dec; 22(6):900-5. PubMed ID: 14680076
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin.
Oury TD; Thakker K; Menache M; Chang LY; Crapo JD; Day BJ
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):164-9. PubMed ID: 11509325
[TBL] [Abstract][Full Text] [Related]
15. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis.
Kelley J; Newman RA; Evans JN
J Lab Clin Med; 1980 Dec; 96(6):954-64. PubMed ID: 6159435
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects and mechanism of saikosaponin-d in mice with bleomycin-induced pulmonary fibrosis].
Zheng JX; Lu KQ; Xia DG; Tian GR; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):808-12. PubMed ID: 20450618
[TBL] [Abstract][Full Text] [Related]
19. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Fang X; Zhu Y; Hu X; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):268-72. PubMed ID: 12133317
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
Yildirim Z; Kotuk M; Iraz M; Kuku I; Ulu R; Armutcu F; Ozen S
Pulm Pharmacol Ther; 2005; 18(5):367-73. PubMed ID: 15939316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
